Search
for

    Sort by

    Research 30 of 1000+

    1. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    2. Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years. PubMed · 2008 · 7 citations
    3. Early vs Delayed Transurethral Surgery in Acute Urinary Retention: Does Timing Make a Difference? The Journal of Urology · 2023
    4. Influence of Clinical and Sociodemographic Factors on the Management, Costs, and Outcomes of Acute Urinary Retention in the Acute Care Setting Urology Practice · 2022
    5. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998 · 1054 citations
    6. Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years European Urology · 2000 · 109 citations
    7. DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 2004 · 235 citations
    8. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    9. Особливості перебігу симптомів нижніх сечових шляхів у чоловіків із доброякісною гіперплазією передміхурової залози та COVID-19 The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · 2021
    10. Дослідження ПРОСПЕКТ IV (ПРОСтамол: ПЕрспективи Комбінованої Терапії) у хворих на доброякісну гіперплазію передміхурової залози Scientific periodicals of Ukraine · 2020
    11. Successes and failures of evidence based urology 2005
    12. PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY The Journal of Urology · 2015
    13. MP09-16 5-ALPHA REDUCTASE INHIBITORS FOR MALE LOWER URINARY TRACT SYMPTOMS: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS 2017
    14. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    15. Dutasteride Drugs · 2008 · 45 citations
    16. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    17. Tamsulosin versus finasteride: effect on bother and urinary flow European Urology Supplements · 2002 · 1 citations
    18. Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? Current Drug Targets · 2015 · 21 citations
    19. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    20. Finasteride Drugs · 1999 · 40 citations
    21. Інгібітор 5α-редуктази дутастерид при лікуванні доброякісної гіперплазії передміхурової залози: системний огляд та мета-аналіз 2021
    22. Finasteride in the treatment of patients with benign prostatic hyperplasia: a review Therapeutics and Clinical Risk Management · 2009 · 33 citations
    23. Long-Term Effectiveness of Finasteride for BPH Journal watch · 2004
    24. Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico Gazzetta Medica Italiana Archivio per le Scienze Mediche · 2026
    25. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    26. Les Visiteurs des malades Nature Clinical Practice Urology · 2011
    27. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    28. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003 · 1707 citations
    29. Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia European Urology · 2000 · 184 citations
    30. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations